WPW
GILD icon

Winthrop Partners - WNY’s Gilead Sciences GILD Stock Holding History

Winthrop Partners - WNY’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$6.34K Buy
100
+39
+64% +$2.55K ﹤0.01% 264
2019
Q2 		$4.12K Hold
61
– – ﹤0.01% 211
2019
Q1 		$4.02K Hold
61
– – ﹤0.01% 216
2018
Q4 		$3.81K Hold
61
– – ﹤0.01% 229
2018
Q3 		$4.71K Hold
61
– – ﹤0.01% 267
2018
Q2 		$4.32K Hold
61
– – ﹤0.01% 286
2018
Q1 		$4.5K Buy
+61
New +$4.85K ﹤0.01% 385

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Winthrop Partners - WNY's GILD Position: Q3 2019 in Review

Winthrop Partners - WNY increased its Gilead Sciences (GILD) stake by 64% in Q3 2019, buying an estimated $2.55K and bringing the position to 100 shares worth $6.34K. The position accounts for ﹤0.01% of the portfolio, ranked #264.

Winthrop Partners - WNY first reported a position in GILD in Q1 2018 and has held it in 7 quarters since. 1,462 funds tracked by Wall St. Rank hold GILD as of Q3 2019.

  • Winthrop Partners - WNY held 100 shares of Gilead Sciences worth $6.34K as of Q3 2019.
  • Winthrop Partners - WNY bought 39 Gilead Sciences shares in Q3 2019, an estimated $2.55K.
  • Gilead Sciences made up ﹤0.01% of Winthrop Partners - WNY's portfolio in Q3 2019, its #264 holding.
  • Winthrop Partners - WNY first reported a position in Gilead Sciences in Q1 2018 and has held it in 7 quarters since.
  • 1,462 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2019.

Based on Winthrop Partners - WNY's 13F filing for Q3 2019, filed 28 Oct 2019.